Dr. Marco Ruiz is a Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, myelodysplastic syndrome, myelofibrosis, HIV related malignancies, stem cell transplants, geriatric oncology, and palliative medicine at the Miami Cancer Institute in Miami, Florida. He is also an experienced bone marrow transplant specialist and is active in cancer research. Growing up the son of a nurse, Dr. Ruiz knew at a young age that he wanted to pursue a career in medicine. But it was his father’s battle with cancer that sparked a passion for helping patients with the disease.
A native of Chicago, Jim Celebucki holds a bachelor’s degree in Political Science and a law degree from the University of Illinois-Urbana. He practiced law for 31 years, much of that time providing advice and representation to college students at the University of Illinois-Chicago. He first came to GRACE when his wife Liz was diagnosed with stage IV lung cancer in July, 2008. As many continue to do, he used the information provided by Dr. West and his colleagues to become knowledgeable about lung cancer and its treatment. Jim became a forum moderator in January, 2010 to assist Dr.
Targeted Therapies Forum 2017 -It's a Wrap
View the videos from the webcast from the Targeted Therapies Patient Forum 2017 in Cleveland, Ohio.
Many physicians worship evidence-based medicine, which is generally a very good practice that ensures that medical practice isn’t dictated by our biases and assumptions but rather on interventions that we have proven show benefits that exceed their anticipated risks.
Targeted Therapies in Lung Cancer Patient Forum 2017
The 2017 Targeted Therapies in Lung Cancer Patient Forum 2017 in Cleveland Ohio has wrapped! Visit our page for the webcast videos!
On Saturday, September 16, 2017, patients, caregivers, family members and friends joined GRACE in Cleveland at the Taussig Cancer Center for a full day of discussion on Targeted Therapies in Lung Cancer. We are thrilled that people joined us for this amazing and informative day.